Exclusive

Publication

Byline

Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and... Read More


Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asci... Read More


Singapore Clinical Trial: A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with chemotherapy followed by asciminib plus blinatumomab in pediatric, adolescent, and young adult participants with relapsed or refractory BCR::ABL1-positive (Philadelphia positive, Ph+) or BCR::ABL1-like (Ph-like) acute lymphoblastic leukemia (ALL)

Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib wit... Read More


Singapore Clinical Trial: A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC determined ineligible for PD(L)1 therapy based on PD-L1 negative disease

Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy... Read More


Singapore Clinical Trial: CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxel and Gemcitabine versus Placebo in Combination with Nab-paclitaxel and Gemcitabine in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion

Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitax... Read More


Lay's(R) Turns its INR 20 Pack into a Chance to Meet Ranbir Kapoor

India, Sept. 27 -- With its new 'Lay's(R) Kholo, Ranbir Se Milo' contest, the brand is giving fans a chance to win rewards worth INR 2 crore*, including an opportunity to meet Ranbir Kapoor. National... Read More


'I have never been a guy who practised a lot': Virat Kohli's unfazed admission after another masterclass against WI

India, Sept. 27 -- Virat Kohli offered an intriguing glimpse into the methods behind his longevity after producing a vintage ODI masterclass against West Indies in Thiruvananthapuram, revealing that, ... Read More


Fact Check: Will Aliyah Boston Miss the Indiana Fever's WNBA Playoff Opener vs Las Vegas Aces? Latest Injury Update

India, Sept. 27 -- The Indiana Fever are hours away from opening their 2026 WNBA playoff campaign against the Las Vegas Aces, but Aliyah Boston's injury status has emerged as a major talking point. Bo... Read More


Ashutosh Ranka says team CJP's 'illegal detention' by Assam Police 'finally ended'; Dipke reacts

India, Sept. 27 -- Ashutosh Ranka and other Cockroach Janta Party volunteers, who were detained by the Assam Police earlier in the day, have now been released, the CJP co-convenor said in a social pos... Read More


Patrick Mahomes injury update: Will he be fit for Week 4? Insider shares positive news ahead of Dolphins game

India, Sept. 27 -- The Kansas City Chiefs have missed Patrick Mahomes for two weeks straight as the 2026-27 NFL season started. On Sunday, as the Chiefs play the Miami Dolphins at Hard Rock Stadium to... Read More